Quince Therapeutics
$1.37
59
+$0.03+2.24% Friday 20:00
Statistics
Day High
1.45
Day Low
1.28
52W High
44
52W Low
0.8
Volume
2,451,600
Avg. Volume
-
Mkt Cap
76.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19MayExpected
Expected EPS
-1.558
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-113.66MNet Income
Analyst Ratings
0Average Price Target
The highest estimate is 0.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 100%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow QNCX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sangamo Therapeutics
SGMO
Mkt Cap104.07M
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
Editas Medicine
EDIT
Mkt Cap287.74M
Intellia Therapeutics
NTLA
Mkt Cap1.59B
Voyager Therapeutics
VYGR
Mkt Cap222.9M
Protagonist Therapeutics
PTGX
Mkt Cap6.31B
Fate Therapeutics
FATE
Mkt Cap144.17M
Regenxbio
RGNX
Mkt Cap454.19M
About
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
Show more...
CEO
Dr. Dirk Thye M.D.
Employees
36
Country
United States
ISIN
US22053A2069
Listings
0 Comments
Share your thoughts
FAQ
What is Quince Therapeutics stock price today?▼
The current price of QNCX is $1.37 USD — it has increased by +2.24% in the past 24 hours. Watch Quince Therapeutics stock price performance more closely on the chart.
What is Quince Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quince Therapeutics stocks are traded under the ticker QNCX.
Is Quince Therapeutics stock price growing?▼
QNCX stock has risen by +0.51% compared to the previous week, the month change is a +41.24% rise, over the last year Quince Therapeutics has showed a -86.16% decrease.
What is Quince Therapeutics market cap?▼
Today Quince Therapeutics has the market capitalization of 76.28M
When is the next Quince Therapeutics earnings date?▼
Quince Therapeutics is going to release the next earnings report on May 19, 2026.
What were Quince Therapeutics earnings last quarter?▼
QNCX earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.22 USD resulting in a -16.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quince Therapeutics revenue for the last year?▼
Quince Therapeutics revenue for the last year amounts to 0 USD.
What is Quince Therapeutics net income for the last year?▼
QNCX net income for the last year is -113.66M USD.
How many employees does Quince Therapeutics have?▼
As of April 18, 2026, the company has 36 employees.
In which sector is Quince Therapeutics located?▼
Quince Therapeutics operates in the Health & Wellness sector.
When did Quince Therapeutics complete a stock split?▼
The last stock split for Quince Therapeutics was on April 13, 2026 with a ratio of 1:10.
Where is Quince Therapeutics headquartered?▼
Quince Therapeutics is headquartered in South San Francisco, United States.